Abstract
We have investigated the morphology, growth and gene expression of smooth muscle cell (SMC) cultures derived from advanced atherosclerotic plaques and from non-plaque-containing aorta of individual apolipoprotein-E-deficient mice. The initial outgrowth of cells was faster from plaques (P) than from non-plaque segments (NP), but the cells in P cultures divided more slowly than NP cells in subcultures. By the 6th passage, the general growth pattern, morphology, ploidy and response to mitogenic factors of the cells were no longer consistently different in P and NP cultures. However, by the use of differential display, several transcripts were identified that were differentially expressed in three independent pairs of P and NP cultures. One of the transcripts, from a type VIII collagen gene, was elevated in all the P cultures compared to their NP counterparts even at the 40th passage. The α1 type VIII collagen transcripts were also readily detectable by RT-PCR in freshly dissected plaques, but not in the normal parts of aortas from the apolipoprotein-E-deficient mice. In situ hybridization showed that the transcripts were limited to the fibrous cap of plaques. Thus, SMCs from atherosclerotic plaques produce type VIII collagen and this differential expression continues when the cells are maintained in tissue culture.
References
1.
Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801–809.
2.
Benditt EP, Benditt JM: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973;70:1753–1756.
3.
Schwartz SM, Campbell GR, Campbell JH: Replication of smooth muscle cells in vascular disease. Circ Res 1986;58:427–444.
4.
Chamley-Campbell J, Campbell GR, Ross R: The smooth muscle cell in culture. Physiol Rev 1979;59:1–61.
5.
Gimbrone MA Jr, Cotran RS: Human vascular smooth muscle in culture. Growth and ultrastructure. Lab Invest 1975;33:16–27.
6.
Chamley JH, Campbell GR, McConnell JD, Groschel-Stewart U: Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture. Cell Tiss Res 1977;177:503–522.
7.
Lemire JM, Covin CW, White S, Giachelli CM, Schwartz SM: Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol 1994;144:1068–1081.
8.
Bochaton-Piallat ML, Gabbiani F, Ropraz P, Gabbiani G: Age influences the replicative activity and the differentiation features of cultured rat aortic smooth muscle cell populations and clones. Arterioscler Thromb 1993;13:1449–1455.
9.
Pietila K, Nikkari T: Enhanced growth of smooth muscle cells from atherosclerotic rabbit aortas in culture. Atherosclerosis 1980;36:241–248.
10.
Orekhov AN, Andreeva ER, Krushinsky AV, Smirnov VN: Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta. Med Biol 1984;62:255–259.
11.
Yoshida Y, Mitsumata M, Yamane T, Tomikawa M, Nishida K: Morphology and increased growth rate of atherosclerotic intimal smooth-muscle cells. Arch Pathol Lab Med 1988;112:987–996.
12.
Naito M, Kuzuya M, Funaki C, Nakayama Y, Asai K, Kuzuya F: Separation and characterization of macrophages and smooth muscle cells in rabbit atherosclerotic lesions. Artery 1987;14:266–282.
13.
Moss NS, Benditt EP: Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics. Am J Pathol 1975;78:175–190.
14.
Pietila K, Yla-Herttuala S, Rantala I, Nikkari T: Characterization of cells cultured from advanced atherosclerotic lesions of the rabbit. Med Biol 1982;60:221–225.
15.
Bennett MR, Littlewood TD, Schwartz SM, Weissberg PL: Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res 1997;81:591–599.
16.
Reddick RL, Zhang SH, Maeda N: Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 1994;14:141–147.
17.
Gordon D, Mohai LG, Schwartz SM: Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells. Circ Res 1986;59:633–644.
18.
Hosang M, Rouge M: Human vascular smooth muscle cells have at least two distinct PDGF receptors and can secrete PDGF-AA. J Cardiovasc Pharmacol 1989;14:S22–S26.
19.
D’Amore PA, Smith SR: Growth factor effects on cells of the vascular wall: A survey. Growth Factors 1993;8:61–75.
20.
Conroy SC, Hart CE, Perez-Reyes N, Giachelli CM, Schwartz SM, McDougall JK: Characterization of human aortic smooth muscle cells expressing HPV16 E6 and E7 open reading frames. Am J Pathol 1995;147:753–762.
21.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–159.
22.
Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992;257:967–971.
23.
Wang AM, Doyle MV, Mark DF: Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989;86:9717–9721.
24.
Miyamoto Y, Sancar A: Vitamin B2-based blue-light photoreceptors in the retinohypothalamic tract as the photoactive pigments for setting the circadian clock in mammals. Proc Natl Acad Sci USA 1998;95:6097–6102.
25.
Fager G, Hansson GK, Ottosson P, Dahllof B, Bondjers G: Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Exp Cell Res 1988;176:319–335.
26.
Muragaki Y, Shiota C, Inoue M, Ooshima A, Olsen BR, Ninomiya Y: α1(VIII)-collagen gene transcripts encode a short-chain collagen polypeptide and are expressed by various epithelial, endothelial and mesenchymal cells in newborn mouse tissues. Eur J Biochem 1992;207:895–902.
27.
Chatterjee S: Role of oxidized human plasma low density lipoproteins in atherosclerosis: Effects on smooth muscle cell proliferation. Mol Cell Biochem 1992;111:143–147.
28.
Bjorkerud S, Bjorkerud B: Growth-stimulating effect of lipoproteins on human arterial smooth-muscle cells and lung fibroblasts is due to apo B-containing lipoproteins, type LDL and VLDL, and requires LDL receptors. Biochim Biophys Acta 1995;1268:237–247.
29.
Shanahan CM, Weissberg PL: Smooth muscle cell heterogeneity. Patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 1998;18:333–338.
30.
Babaev VR, Bobryshev YV, Stenina OV, Tararak EM, Gabbiani G: Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta. Am J Pathol 1990;136:1031–1042.
31.
Majesky MW, Topouzis S: Smooth muscle lineage diversity and atherosclerosis; in Woodford FP, Davignon J, Sniderman A (eds): Atherosclerosis X. New York, Elsevier, 1995, pp 56–60.
32.
Sage H, Pritzl P, Bornstein P: A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture. Biochemistry 1980;19:5747–5755.
33.
Sutmuller M, Bruijn JA, de Heer E: Collagen types VIII and X, two non-fibrillar, short-chain collagens. Structure homologies, functions and involvement in pathology. Histol Histopathol 1997;12:557–566.
34.
Alitalo K, Bornsterin P, Vaheri A, Sage H: Biosynthesis of an unusual collagen type by human astrocytoma cells in vitro. J Biol Chem 1983;258:2653–2661.
35.
Iruela-Arispe ML, Diglio CA, Sage EH: Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. Arterioscler Thromb 1991;11:805–815.
36.
Olsen BR, Ninomiya Y: Short chain collagens (types VIII and X); in Kreis R, Vale R (eds): Guide Book to the Extracellular Matrix and Adhesion Molecules. Oxford, Oxford University Press, 1993; pp 47–48.
37.
Rosenblum ND, Briscoe DM, Karnovsky MJ, Olsen BR: α1-VIII collagen is expressed in the rat glomerulus and in resident glomerular cells. Am J Physiol 1993;264:F1003–F1010.
38.
MacBeath JRE, Kielty CM, Shuttleworth CA: Type VIII collagen is a product of vascular smooth-muscle cells in development and disease. Biochem J 1996;319:993–998.
39.
Bendeck MP, Regenass S, Tom WD, Giachelli CM, Schwartz SM, Hart C, Reidy MA: Differential expression of α1 type VIII collagen in injured platelet-derived growth factor-BB-stimulated rat carotid arteries. Circ Res 1996;79:524–531.
40.
Sibinga NE, Foster LC, Hsieh CM, Perrella MA, Lee WS, Endege WO, Sage EH, Lee ME, Haber E: Collagen VIII is expressed by vascular smooth muscle cells in response to vascular injury. Circ Res 1997;80:532–541.
41.
Weitkamp B, Cullen P, Plenz G, Robenek H, Rauterberg J: Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque. FASEB J 1999;13:1445–1457.
42.
Plenz G, Dorszewski A, Volker W, Ko YS, Severs NJ, Breithardt G, Robenek H: Cholesterol-induced changes of type VIII collagen expression and distribution in carotid arteries of rabbits. Arterioscler Thromb Vasc Biol 1999;19:2395–2404.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
